WebMay 7, 2015 · Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment. Antonino Carbone, ... WebApr 1, 2024 · Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin lymphoma. There is limited data on treatment, …
New Approaches to the Treatment of Relapsed or Refractory …
WebMar 3, 2024 · PIT-565 is under clinical development by Novartis and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According to GlobalData, Phase I drugs for Primary Mediastinal B-Cell Lymphoma have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how PIT-565’s ... WebNov 22, 2024 · A total of 567 patients with Hodgkin lymphoma registered at the hospital. Sixty of the patients (10.6%) had either primary progressive or refractory disease or … high point furniture premarket 2021
Novel Therapies and Approaches to Relapsed/Refractory HL …
WebApr 11, 2024 · Investigators believe the design of MT-0169 may allow it to overcome the primary mechanisms of tumor resistance to daratumumab (Darzalex). Investigators of … WebJun 16, 2024 · Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Approximately 30% to 40% of patients will develop relapsed/refractory (R/R) DLBCL, leading to significant morbidity and mortality. Salvage chemoimmunotherapy followed by high-dose chemotherapy and autologous stem cell rescue (HDT-ASCR) is the … WebJan 31, 2024 · Purpose of trial. The aim of this trial is to establish the safety and work out the best dose of a new treatment called GEN3013 (also called DuoBody ®-CD3xCD20).It is for people with B-cell non-Hodgkin lymphoma that is getting worse (progressing), has come back or has not responded to other treatment. how many beams for a shop concrete pad